# Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis.

> PubMed lists PMID 41938304 in AACE endocrinology and diabetes as Journal Article, Review, with publication-date metadata of 2026-01-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41938304-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-13
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41938304-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41938304-semaglutide-v1.json
- Content SHA-256: `39b3429cbb94259fcc038511a0cd2408170bef618210bd6c46842f94f2df84d0`

## Claims and source pins

### Headline

Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis. ([`pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2`](#source-pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2))

### Summary

PubMed lists PMID 41938304 in AACE endocrinology and diabetes as Journal Article, Review, with publication-date metadata of 2026-01-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2`](#source-pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2))

### Paragraph 1

PubMed lists PMID 41938304 in AACE endocrinology and diabetes as Journal Article, Review, with publication-date metadata of 2026-01-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2`](#source-pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2`](#source-pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2))

## Sources

<a id="source-pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2"></a>
- **Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis. · retained source version 1:2026-08-13:current:2ea8ee5dcfc214f0ca25674823b33690a839e781e74430980e6137ba7721c140** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41938304/) (`pubmed-observation-pmid-41938304-2026-08-13-2ea8ee5dcfc2`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41938304-semaglutide-v1.json SHA-256: 39b3429cbb94259fcc038511a0cd2408170bef618210bd6c46842f94f2df84d0.